PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 13.
Other Expenses of Issuance and Distribution.
The estimated expenses payable by us in connection with the offering described in this registration statement (other than the underwriting discount and commissions) will be as follows:
| Legal fees and expenses | | | | $ | 250,000 | | |
| Accounting fees and expenses | | | | | 45,000 | | |
| SEC/FINRA Expenses | | | | | 60,093 | | |
| Travel and road show | | | | | 20,000 | | |
| Nasdaq listing and filing fees | | | | | 75,000 | | |
| Printing and engraving expenses | | | | | 35,000 | | |
| Miscellaneous expenses | | | | | 14,907 | | |
| Total offering expenses | | | | $ | 500,000 | | |
Item 14.
Indemnification of Directors and Officers.
Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, civil fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud or willful default. We may purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
Item 15.
Recent Sales of Unregistered Securities.
In March 2021, our sponsor purchased an aggregate of 5,912,500 founder shares, for an aggregate offering price of $25,000 at an average purchase price of approximately $0.004 per share. In September 2021, we effected a dividend of approximately 0.017 shares for each outstanding Class B ordinary share, resulting in there being an aggregate of 6,015,000 founder shares outstanding. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D.
In addition, our sponsor, Cantor, and CCM have committed, pursuant to a written agreement, to purchase an aggregate of 1,000,000 placement units, at a price of $10.00 per placement unit, or $10,600,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 1,000,000 placement units (or up to 1,060,000 placement units if the underwriters’ over-allotment option is exercised in full), our sponsor has committed to purchase 770,000 placement units (or 795,500 placement units if the underwriters’ over-allotment option is exercised), Cantor has committed to purchase an aggregate of 200,000 placement units (or 230,000 placement units if the underwriters’ over-allotment option is exercised in full), and CCM, has committed to purchase an aggregate of 30,000 placement units (or 34,500 placement units if the underwriters’ over-allotment option is exercised in full). This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.